CN102139057A - Healthcare tea capable of lowering glucose - Google Patents
Healthcare tea capable of lowering glucose Download PDFInfo
- Publication number
- CN102139057A CN102139057A CN2011100767039A CN201110076703A CN102139057A CN 102139057 A CN102139057 A CN 102139057A CN 2011100767039 A CN2011100767039 A CN 2011100767039A CN 201110076703 A CN201110076703 A CN 201110076703A CN 102139057 A CN102139057 A CN 102139057A
- Authority
- CN
- China
- Prior art keywords
- present
- health preserving
- lowering
- components
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 17
- 239000008103 glucose Substances 0.000 title abstract description 17
- 241001122767 Theaceae Species 0.000 title description 25
- 210000000582 semen Anatomy 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 12
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 10
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 9
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims abstract 3
- 239000008280 blood Substances 0.000 claims description 30
- 210000004369 blood Anatomy 0.000 claims description 30
- 230000036541 health Effects 0.000 claims description 27
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 21
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000195955 Equisetum hyemale Species 0.000 abstract 1
- 241000628997 Flos Species 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 14
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- JQNVCUBPURTQPQ-UHFFFAOYSA-N (25R)-Inokosterone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(CO)C)CCC33O)C)C3=CC(=O)C21 JQNVCUBPURTQPQ-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 229940118148 Aldose reductase inhibitor Drugs 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- JQNVCUBPURTQPQ-FTWMDKANSA-N Inokosterone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CC[C@H](CO)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 JQNVCUBPURTQPQ-FTWMDKANSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003288 aldose reductase inhibitor Substances 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- -1 blood pressure Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JQNVCUBPURTQPQ-XDWLXSIGSA-N inokosterone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(CO)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 JQNVCUBPURTQPQ-XDWLXSIGSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
The invention relates to a healthcare tea capable of lowering glucose, which comprises ganoderma lucidum spore powder, folium mori, burdock root, black soya beans, prepared rhizoma polygonati, wax gourd seeds, flos notoginseng, semen cassiae, hawthorn and scouring rush, and is prepared by the following steps of: grinding and crushing the components in proportion; sieving the powder of the components through a 150-300 meshes sieve; and uniformly mixing the components. The healthcare tea has a good effect of lowering the glucose, does not have any side effect for long-time administration, needs low price, is suitable for regular administration, and has a certain healthcare function for the body.
Description
Technical field
The present invention relates to a kind of blood sugar lowering health preserving tea.
Background technology
Diabetes (diabetes) are by inherited genetic factors, immunologic function disorder, infected by microbes and toxin thereof, the free radical toxin, the various virulence factors of Nervous and Mental Factors or the like act on body and cause hypoinsulinism, insulin resistant etc. and the sugar that causes, protein, fat, a series of metabolism disorder syndromes such as power and water Xie Zhi, be main feature clinically with the hyperglycemia, it is the pertinacious disease that present global medical circle is generally acknowledged, complication is a lot, as hyperlipidemia, hypertension, cataract, diabetic foot, nephropathy, neuropathy, retinopathy and cardiovascular and cerebrovascular disease etc., serious harm human life health.Along with the raising of quality of life and the development process of China's aging society, the sickness rate of diabetes increases sharply, and presents the trend of rejuvenation.China's diabetics has reached about 5,000 ten thousand, accounts for 1/5th of world's diabetes total number of persons, and prevalence occupies the second place of the world, and increase with 3000 people's speed every day at least.
At present, the main method of treatment diabetes is to take Chinese medicine and western medicine.The traditional Chinese medical science is used traditional traditional Chinese medical science medicine, and dialectical executing controlled, and its treatment cycle is long, and it is slow to take effect, and needs when taking Chinese medicine to decoct, and carries inconvenience.The traditional Chinese medical science adopts the medicine of aldose reductase inhibitor, biguanides and sulphanylureas mostly, and these drug side effectes are big, and cost an arm and a leg.
Summary of the invention
Technical problem to be solved by this invention provides good, the cheap blood sugar lowering health preserving tea of a kind of hypoglycemic effect.
The present invention adopts following technical scheme for solving its technical problem:
The present invention adopts following components in part by weight to form: Sporoderm-broken Ganoderma Lucidum Spore powder 1-5, Folium Mori 1-3, Radix Arctii 1-8, Semen sojae atricolor 1-8, Rhizoma Polygonati (processed) 1-5, Semen Benincasae 1-7, flower of Radix Notoginseng 1-5, Semen Cassiae 1-6, Fructus Crataegi 1-4, Herba Equiseti Hiemalis 1-3.
Good effect of the present invention is as follows:
The present invention is on the basis of tradition prescription, go through ten surplus year clinical practice, form through the processing allotment of every flavor Chinese medicinal ingredients being carried out science.Ten flavor Chinese medicines of health preserving tea of the present invention all are the medicine-food two-purpose medicine, take for a long time without any side effects, the lesions of liver and kidney of avoiding taking Western medicine for a long time, in a large number and being brought.Take 15 days diabeticss of health preserving tea of the present invention and can feel light from head to foot, the biochemical indicator of the blood glucose after 30 days is normal substantially.It is good that the patient of 90 ﹪ takes the back hypoglycemic effect, and relapse rate is very low.Health preserving tea of the present invention is cheap, is fit to take for a long time, and health is had certain health care.
Health preserving tea of the present invention is mainly used in blood sugar lowering, and hyperlipidemia, hypertension, fatty liver, obesity, constipation are also had good effect, can be used as auxiliary treatment.
The component of health preserving tea of the present invention consists of:
1, Sporoderm-broken Ganoderma Lucidum Spore powder: medicine-food two-purpose, long-term edible safety has no side effect.Compendium of Material Medica is classified top grade suitable all groups as.Be rich in polysaccharide, triterpene, aminoacid, vitamin, trace element, have mind tranquilizing and the heart calming, spleen benefiting and stimulating the appetite, removing fatigue, improve body immunity, reducing pressure and sugar blood fat reducing, improve myocardial ischemia, suppress the effect that cancer is grown, immune system, nervous system, E﹠M system and cardiovascular system etc. are all had regulating action.
2, Folium Mori: medicine-food two-purpose, contain inokosterone, kind of active substance surplus the ecdysterone etc. ten is returned lung, and Liver Channel has blood pressure lowering, and blood fat reducing, blood sugar lowering, antiinflammatory action are called by the physician on " angle's leaf ".
3, Radix Arctii: medicine-food two-purpose, rich in proteins, cellulose, carotene, vitamin C, mineral etc., have relieving constipation, reduction body inner cholesterol and toxin, the refuse effect of accumulating in vivo, blood glucose, blood pressure, blood fat there is tangible regulating action, kidney invigorating and YANG supporting, remove unnecessary free radical in the human body, suppress cell carcinogenesis.
4, Semen sojae atricolor: medicine-food two-purpose, contain 18 seed amino acids, unsaturated fatty acid, trace element, anthocyanidin, return spleen, kidney channel, the kidney invigorating black hair that dispels the wind, nourishes blood, blood glucose there is the better controlled effect.
5, Rhizoma Polygonati (processed): medicine-food two-purpose, have boosting qi and nourishing yin, the effect of spleen invigorating lung moistening, kidney tonifying, resisting fatigue, blood pressure lowering, blood sugar lowering, blood fat reducing especially has better curative effect to diabetes.
6, Semen Benincasae: sweet in the mouth opens the spleen relieving constipation, and the fat eliminating diuretic has good adjustment of treatment effect for fat and fatty liver, hyperlipidemia.
7, flower of Radix Notoginseng: medicine-food two-purpose, the sweet cold of nature and flavor, the heat clearing away suppressing the hyperactive liver, the QI invigorating of refreshing oneself contains arasaponin, has blood sugar lowering, improves blood supply of cardiac muscle, effect such as fat-reducing.
8, Semen Cassiae: contain various active materials such as saccharide, protein, trace element, steroidal compounds, liver heat removing and eyesight improving, expelling wind and removing dampness, tonifying kidney and improving eyesight, function of gallbladder promoting, protect the liver, loosening bowel to relieve constipation, have the effect of good blood sugar lowering, blood pressure lowering, relieving constipation, fat-reducing.
9, Fructus Crataegi: medicine-food two-purpose, contain multivitamin, saccharide, have blood fat reducing, blood pressure lowering, strengthen the cardiac muscle effect.
10, Herba Equiseti Hiemalis: GUIXIN, liver, stomach, urinary bladder channel, liver heat removing and eyesight improving, inducing diuresis for treating stranguria syndrome.The clinical diabetes that are used for the treatment of.
More than in each component, Sporoderm-broken Ganoderma Lucidum Spore powder and Folium Mori are monarch drug, can regulate blood sugar control, and islet function is had repair; Radix Arctii, Semen sojae atricolor and Rhizoma Polygonati (processed) are ministerial drug, can strengthen the adjusting control to blood glucose; Flower of Radix Notoginseng, Semen Cassiae, Fructus Crataegi, Semen Benincasae are adjuvant drug, have blood sugar regulation, the effect of cholesterol reducing and triglyceride.Herba Equiseti Hiemalis is a messenger drug, is guiding drug in the traditional Chinese medical science, and the led cluster medicine leads directly to sick internal organs.
The used ten flavor Chinese medicines of the present invention all are selected from the commercially available 1 grade of product in original producton location.Used component drug all will be concocted according to traditional method and form, and the Sporoderm-broken Ganoderma Lucidum Spore powder powder is to adopt the modern crafts breaking cellular wall.Prescription ratio compatibility in strict accordance with traditional monarch is made health preserving tea of the present invention, all adopts ultraviolet radiation disinfection to handle, and the qualified back of quality inspection restrains with the heat sealing machine press seal in the bag of making tea vacuum packaging by every bag 20.1-2 bags of every days, put in the water tumbler, be taken after being infused in hot water or decoction with boiled water, circulation brews till colourless repeatedly.
Adopt the clinical criteria of health preserving tea blood sugar lowering of the present invention as follows:
1, produce effects: take health preserving tea of the present invention after 3 months, fasting glucose≤6.8mmol/L, syndrome alleviates.
2, effective: take health preserving tea of the present invention after 3 months, fasting glucose≤8.3mmol/L, syndrome makes moderate progress.
3, invalid: take health preserving tea of the present invention after 3 months, blood glucose descends and does not reach above-mentioned standard, and the blood glucose symptom does not have obvious improvement.
Shi Pingshan (man), Li Caiying 290 people such as (woman) are diagnosed as diabetes through examination in hospital above county level.In the period of surplus 1999 to 2010 ten, 290 patients are carried out the treating diabetes clinical observation: produce effects 156 people, effective 120 people, invalid 14 people.
Model case:
1, Li Caiying, the woman, 69 years old, Yongnian lived in the county town, retirement, from 2004 through the city center hospital diagnosis for suffering from diabetes, blood glucose (on an empty stomach) 10.5mmol/L, (after the meal) 17.2 mmol/L, through taking health preserving tea of the present invention check in three months: blood glucose (on an empty stomach) 6.2 mmol/L, (after the meal) 9.8 mmol/L reach produce effects, and the patient still is interrupted so far and takes health preserving tea of the present invention as health care.
2, Shi Pingshan, the man, 48 years old, Yongnian lived in the county town, procuratorate's work, blood glucose (on an empty stomach) 12mmol/L, (after the meal) 16 mmol/L, taking health preserving tea of the present invention from 2009 checked after 3 months: blood glucose (on an empty stomach) 6.0 mmol/L, (after the meal) 9.1 mmol/L reach produce effects.
3, Han Lijun, the man, 66 years old, live in Yongnian County, retirement, blood glucose (on an empty stomach) 11 mmol/L, (after the meal) 15 mmol/L are diagnosed as diabetes through county hospital.Took glossy-ganoderma life-nutrition tea after 3 months from 2010, blood glucose (on an empty stomach) 6.1 mmol/L, (after the meal) 9.5 mmol/L reach produce effects.
The specific embodiment
Embodiment 1:
Present embodiment adopts following components in part by weight: Sporoderm-broken Ganoderma Lucidum Spore powder 3, Folium Mori 1, Radix Arctii 5, Semen sojae atricolor 2, Rhizoma Polygonati (processed) 5, Semen Benincasae 1, flower of Radix Notoginseng 3, Semen Cassiae 4, Fructus Crataegi 1, Herba Equiseti Hiemalis 3.
The making step of present embodiment health preserving tea is as follows:
(1) take by weighing component by following weight ratio:
Sporoderm-broken Ganoderma Lucidum Spore powder 3, Folium Mori 1, Radix Arctii 5, Semen sojae atricolor 2, Rhizoma Polygonati (processed) 5, Semen Benincasae 1, flower of Radix Notoginseng 3, Semen Cassiae 4, Fructus Crataegi 1, Herba Equiseti Hiemalis 3.
(2) each component in (1) was ground 200 mesh sieves, mix homogeneously is made health preserving tea of the present invention.
Embodiment 2:
Present embodiment adopts following components in part by weight: Sporoderm-broken Ganoderma Lucidum Spore powder 1, Folium Mori 2, Radix Arctii 1, Semen sojae atricolor 8, Rhizoma Polygonati (processed) 3, Semen Benincasae 4, flower of Radix Notoginseng 1, Semen Cassiae 6, Fructus Crataegi 2, Herba Equiseti Hiemalis 1.
The making step of present embodiment health preserving tea each component as different from Example 1 ground 150 mesh sieves, and mix homogeneously is made health preserving tea of the present invention.
Embodiment 3:
Present embodiment adopts following components in part by weight: Sporoderm-broken Ganoderma Lucidum Spore powder 5, Folium Mori 3, Radix Arctii 8, Semen sojae atricolor 1, Rhizoma Polygonati (processed) 1, Semen Benincasae 7, flower of Radix Notoginseng 5, Semen Cassiae 1, Fructus Crataegi 4, Herba Equiseti Hiemalis 2.
The making step of present embodiment health preserving tea each component as different from Example 1 ground 300 mesh sieves, and mix homogeneously is made health preserving tea of the present invention.
Claims (1)
1. blood sugar lowering health preserving tea is characterized in that it is made up of following components in part by weight: Sporoderm-broken Ganoderma Lucidum Spore powder 1-5, Folium Mori 1-3, Radix Arctii 1-8, Semen sojae atricolor 1-8, Rhizoma Polygonati (processed) 1-5, Semen Benincasae 1-7, flower of Radix Notoginseng 1-5, Semen Cassiae 1-6, Fructus Crataegi 1-4, Herba Equiseti Hiemalis 1-3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110076703.9A CN102139057B (en) | 2011-03-29 | 2011-03-29 | Healthcare tea capable of lowering glucose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110076703.9A CN102139057B (en) | 2011-03-29 | 2011-03-29 | Healthcare tea capable of lowering glucose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102139057A true CN102139057A (en) | 2011-08-03 |
| CN102139057B CN102139057B (en) | 2015-04-15 |
Family
ID=44406999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110076703.9A Expired - Fee Related CN102139057B (en) | 2011-03-29 | 2011-03-29 | Healthcare tea capable of lowering glucose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102139057B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103271395A (en) * | 2013-05-23 | 2013-09-04 | 安徽野岭饮料食品有限公司 | Lotus root juice drink and preparation method thereof |
| CN103653143A (en) * | 2013-12-10 | 2014-03-26 | 济南凯因生物科技有限公司 | Health drink for reducing blood pressure and blood fat and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158737A (en) * | 1996-03-04 | 1997-09-10 | 济南市中心医院 | Baged medicine for diabetes and its preparation |
| CN1939418A (en) * | 2005-09-30 | 2007-04-04 | 张晓峰 | Chinese medicinal herb composition with food and medicine consangunity |
| CN101695376A (en) * | 2009-10-14 | 2010-04-21 | 寇开勤 | Health-care food for preventing diabetes |
-
2011
- 2011-03-29 CN CN201110076703.9A patent/CN102139057B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158737A (en) * | 1996-03-04 | 1997-09-10 | 济南市中心医院 | Baged medicine for diabetes and its preparation |
| CN1939418A (en) * | 2005-09-30 | 2007-04-04 | 张晓峰 | Chinese medicinal herb composition with food and medicine consangunity |
| CN101695376A (en) * | 2009-10-14 | 2010-04-21 | 寇开勤 | Health-care food for preventing diabetes |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103271395A (en) * | 2013-05-23 | 2013-09-04 | 安徽野岭饮料食品有限公司 | Lotus root juice drink and preparation method thereof |
| CN103653143A (en) * | 2013-12-10 | 2014-03-26 | 济南凯因生物科技有限公司 | Health drink for reducing blood pressure and blood fat and preparation method thereof |
| CN103653143B (en) * | 2013-12-10 | 2016-03-02 | 河南职业技术学院 | The health drink its preparation method of hypotensive, reducing blood lipid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102139057B (en) | 2015-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102293273A (en) | Health tea capable of adjusting blood pressure, blood sugar and blood fat and preventing thrombus and apoplexy | |
| CN1915399A (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
| CN101037651B (en) | Lucidum mushroom health wine and production method thereof | |
| CN103169793A (en) | Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus | |
| CN104352552A (en) | Food, health care product or medicine composition | |
| CN107114528A (en) | A kind of weight-reducing tea and preparation method thereof | |
| CN104208425B (en) | A kind of Chinese medicine preparation for being used to nurse one's health critical hypertension | |
| CN108185441A (en) | A kind of formula food for treating diabetes and preparation method thereof | |
| CN102640825B (en) | Lipid-lowering tea for regulating blood lipid | |
| CN102139057B (en) | Healthcare tea capable of lowering glucose | |
| CN100509025C (en) | A medicine for treating diabetes | |
| CN102846882A (en) | Chinese medicinal composition for reducing blood sugar | |
| CN101884760B (en) | Chinese medicinal composition for treating diabetes mellitus and preparation method thereof | |
| CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
| CN103933282B (en) | A kind of Chinese medicinal capsule for treating diabetes | |
| CN101066391B (en) | Medicine composition for treating hypertension | |
| CN1285348C (en) | Breast enlarging composition and its preparing method | |
| CN103385963A (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN114712466B (en) | Medicine with weight-reducing and beautifying effects and preparation method thereof | |
| CN101444614B (en) | Pharmaceutical composition with fat burning and firming effect and preparation method thereof | |
| CN102526541A (en) | Composition for effectively conditioning female climacteric syndrome | |
| CN101623378B (en) | Chinese medicament for treating high blood pressure | |
| CN105168873A (en) | Traditional Chinese medicine composition conditioning diabetes and preparation method therefor | |
| CN105998448A (en) | Method for preparing mulberry oral solution for improving immunity and oral solution prepared by same | |
| CN105709117A (en) | Traditional Chinese medicine composition containing argy wormwood leaves and used for female kidney-yang deficiency type ovulation failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 |